1 / 8

Imatinib Mesylate (Gleevec)

Glivec 100mg tablet is an anti neoplastic medicine which is used in the treatment of; 1.tAdvanced myelogenous leukemia (CML), 2. Gastrointestinal stromal tumors (GISTs) and a number of malignancies Glivec 100mg is used as monotherapy, or it may combine with some other medicine in the conditions of certain types of cancer or bone marrow disorders. Glivec 100mg is a tyrosine kinase inhibitor that prohibits BCR-ABL kinase produced by chromosomal rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia

sharonpaula08
Download Presentation

Imatinib Mesylate (Gleevec)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. WELCOME TO APPLE PHARMACEUTICALS

  2. Veenat (100mg&400mg) • Veenat 100mg is a antineoplastic agents and used by alone regimen or together with other medicines for the treatment of different types of cancer or bone marrow conditions, the main ingredient which is used asimatinib . Veenat 100mg will prevents the development of cancer cells in the body. Veenat 100mg is manufactured by NatcoPharma Ltd with 120 capsules in a container. Veenat 100mg strength available is 100mg, 100mg.

  3. DOSAGE : Adult :  PO  Chronic myeloid leukaemia • Chronic phase:  The patients with Chronic phase the drug administrated 400 mg per day, given up to 600 mg/day or 400 mg bid if needed. The patients with Blast crisis or accelerated phase administrated 600 mg per day, up to 400 mg bid if required. Acute lymphoblastic leukaemia :Dose of 600 mg per day with induction, consolidation or maintenance therapy ; Monotherapy in relapsed or refractory acute lymphoblastic leukaemia 400 mg per day up to 400 mg bid is administrated for Unresectable, metastatic GI stromaltumours 400 mg/day. starting with100 mg/day in patients w/ith FIP1L1-PDGF-α fusion kinase is given for Hypereosinophilic syndrome

  4. MECHANISM OF ACTION Imatinib is a protein-tyrosine kinase inhibitor which inhibits the Bcr-Abl tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in chronic myeloid leukemia (CML).

  5. Veenat 400mg • Veenat 400mg is a antineoplastic agents and used by alone regimen or together with other medicines for the treatment of different types of cancer or bone marrow conditions, the main ingredient which is used as imatinib. • Veenat 400mg will prevents the development of cancer cells in the body. Veenat 400mg is manufactured by NatcoPharma Ltd with 120 capsules in a container. Veenat 400mg strength available is 400mg, 100mg.

  6. DOSAGE: Adult : PO  Chronic myeloid leukaemia• Chronic phase:  The patients with Chronic phase the drug administrated 400 mg per day, given up to 600 mg/day or 400 mg bid if needed. The patients with Blast crisis or accelerated phase administrated 600 mg per day, up to 400 mg bid if required. Acute lymphoblastic leukaemia :Dose of 600 mg per day with induction, consolidation or maintenance therapy ; Monotherapy in relapsed or refractory acute lymphoblastic leukaemia 400 mg per day up to 400 mg bid is administrated for Unresectable, metastatic GI stromaltumours 400 mg/day. starting with100 mg/day in patients w/ith FIP1L1-PDGF-α fusion kinase is given for Hypereosinophilic syndrome

  7. MECHANISM OF ACTION • Imatinib is a protein-tyrosine kinase inhibitor which inhibits the Bcr-Abl tyrosine kinase, the constitutive abnormal tyrosine kinase created by the Philadelphia chromosome abnormality in chronic myeloid leukemia (CML). • Myelodysplastic disease: 400 mg per day. Mastocytosis 400 mg per day. starting with100 mg/day if there is analog eosinophilia. Dermatofibrosarcomaprotuberans: 400 mg bid. Veenat 400mg should be taken with food by oral route.

  8. Contact Details Phone :+91-9987711567 Email :info@myapplepharma.com

More Related